Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial

Matthew G. Johnson, Julie M. Strizki, Michelle L. Brown, Hong Wan, Hala H. Shamsuddin, Moti Ramgopal, Diana F. Florescu, Pierre Delobel, Ilsiyar Khaertynova, José F. Flores, Leon F. Fouche, Shan Chwen Chang, Angela Williams-Diaz, Jiejun Du, Jay A. Grobler, Amanda Paschke, Carisa De Anda

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial'. Together they form a unique fingerprint.

Medicine & Life Sciences